What is the treatment for bacterial vaginosis (BV) in men?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Bacterial Vaginosis in Men

Male partners of women with bacterial vaginosis should be treated with a combination of oral metronidazole 400 mg twice daily and 2% clindamycin cream applied topically to the glans penis and upper shaft (under the foreskin if uncircumcised) twice daily for 7 days to prevent recurrence of BV in female partners. 1

Evidence for Male Partner Treatment

The treatment of bacterial vaginosis (BV) has traditionally focused solely on treating women, with no specific recommendations for treating male partners. However, recent high-quality evidence has changed this approach:

  • A 2025 randomized controlled trial published in the New England Journal of Medicine demonstrated that treating male partners significantly reduced BV recurrence rates in women 1
  • The trial was stopped early because treating only the woman was found to be inferior to treating both partners
  • BV recurrence occurred in only 35% of women whose partners received treatment compared to 63% in the standard care group (absolute risk difference of -2.6 recurrences per person-year) 1

Treatment Regimen for Men

Based on the most recent evidence, the recommended treatment for male partners includes:

  • Oral metronidazole 400 mg twice daily for 7 days AND
  • 2% clindamycin cream applied topically to the glans penis and upper shaft (under the foreskin if uncircumcised) twice daily for 7 days 1

Rationale for Male Partner Treatment

The rationale for treating male partners stems from evidence suggesting sexual transmission of BV-associated organisms:

  • Male partners may harbor BV-associated bacteria and reinfect female partners 2
  • Traditional approaches treating only women result in high recurrence rates (up to 50% within 1 year) 3
  • The formation of biofilms may protect BV-causing bacteria from antimicrobial therapy, contributing to persistence 3

Important Considerations and Potential Side Effects

When prescribing treatment for male partners, be aware of:

  1. Potential side effects in men:

    • Nausea
    • Headache
    • Metallic taste 1
  2. Contraindications:

    • Advise against alcohol consumption during metronidazole treatment and for 24 hours afterward due to disulfiram-like reactions 4
  3. Condom use:

    • Clindamycin cream is oil-based and may weaken latex condoms 4
    • Recommend abstinence or non-latex barriers during treatment

Caution Regarding Alternative Approaches

It's important to note that not all topical applications are beneficial:

  • A 2011 study found that topical application of 62% ethyl alcohol in emollient gel to the penis actually increased BV persistence or early recurrence in female partners 5
  • This highlights the importance of using evidence-based treatments rather than alternative approaches

Follow-up Recommendations

After treatment:

  • Partners should complete the full 7-day course of treatment
  • Couples should be advised to return for follow-up if the woman's symptoms persist or recur
  • Consider extended treatment courses for women with recurrent BV (metronidazole 500 mg twice daily for 10-14 days) 3

The evidence clearly supports treating male partners of women with BV using a combination of oral and topical antimicrobials to reduce recurrence rates and improve outcomes for women with this common condition.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.